nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—embryo—colon cancer	0.0471	0.253	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—colon cancer	0.0226	0.121	CbGeAlD
Pentosan Polysulfate—FGF1—blood vessel—colon cancer	0.0209	0.112	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—colon cancer	0.0132	0.0706	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—colon cancer	0.0125	0.0668	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—colon cancer	0.0102	0.0545	CbGeAlD
Pentosan Polysulfate—Sickness—Irinotecan—colon cancer	0.0101	0.0414	CcSEcCtD
Pentosan Polysulfate—FGF1—smooth muscle tissue—colon cancer	0.00979	0.0525	CbGeAlD
Pentosan Polysulfate—FGF1—renal system—colon cancer	0.00942	0.0505	CbGeAlD
Pentosan Polysulfate—FGF2—vagina—colon cancer	0.00918	0.0492	CbGeAlD
Pentosan Polysulfate—FGF1—lymphoid tissue—colon cancer	0.00783	0.042	CbGeAlD
Pentosan Polysulfate—FGF1—digestive system—colon cancer	0.00773	0.0415	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—colon cancer	0.00594	0.0318	CbGeAlD
Pentosan Polysulfate—FGF1—liver—colon cancer	0.00576	0.0309	CbGeAlD
Pentosan Polysulfate—Lacrimation—Irinotecan—colon cancer	0.00479	0.0195	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Capecitabine—colon cancer	0.00459	0.0187	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Fluorouracil—colon cancer	0.00458	0.0187	CcSEcCtD
Pentosan Polysulfate—FGF1—lymph node—colon cancer	0.00442	0.0237	CbGeAlD
Pentosan Polysulfate—Nystagmus—Vincristine—colon cancer	0.00404	0.0165	CcSEcCtD
Pentosan Polysulfate—Menorrhagia—Vincristine—colon cancer	0.0039	0.0159	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Fluorouracil—colon cancer	0.00377	0.0154	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Irinotecan—colon cancer	0.00305	0.0125	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Methotrexate—colon cancer	0.00304	0.0124	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Fluorouracil—colon cancer	0.00292	0.0119	CcSEcCtD
Pentosan Polysulfate—Appetite absent—Methotrexate—colon cancer	0.00282	0.0115	CcSEcCtD
Pentosan Polysulfate—Colitis—Irinotecan—colon cancer	0.0027	0.011	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Vincristine—colon cancer	0.00261	0.0107	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Fluorouracil—colon cancer	0.00246	0.01	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Fluorouracil—colon cancer	0.00223	0.00909	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Capecitabine—colon cancer	0.00208	0.00851	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Capecitabine—colon cancer	0.00204	0.00834	CcSEcCtD
Pentosan Polysulfate—Dehydration—Vincristine—colon cancer	0.00195	0.00796	CcSEcCtD
Pentosan Polysulfate—Dehydration—Irinotecan—colon cancer	0.0019	0.00775	CcSEcCtD
Pentosan Polysulfate—Colitis—Capecitabine—colon cancer	0.00181	0.00738	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Capecitabine—colon cancer	0.00172	0.00702	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Irinotecan—colon cancer	0.00172	0.00702	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Irinotecan—colon cancer	0.00172	0.00702	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Capecitabine—colon cancer	0.0017	0.00695	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Capecitabine—colon cancer	0.0017	0.00695	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Vincristine—colon cancer	0.00165	0.00675	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Fluorouracil—colon cancer	0.00165	0.00672	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Vincristine—colon cancer	0.00164	0.00669	CcSEcCtD
Pentosan Polysulfate—Depression—Vincristine—colon cancer	0.00161	0.00658	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Irinotecan—colon cancer	0.0016	0.00652	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Vincristine—colon cancer	0.00158	0.00643	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Capecitabine—colon cancer	0.00156	0.00635	CcSEcCtD
Pentosan Polysulfate—Sweating—Vincristine—colon cancer	0.00155	0.00632	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Fluorouracil—colon cancer	0.00154	0.0063	CcSEcCtD
Pentosan Polysulfate—Jaundice—Irinotecan—colon cancer	0.00153	0.00626	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Irinotecan—colon cancer	0.00153	0.00626	CcSEcCtD
Pentosan Polysulfate—Sweating—Irinotecan—colon cancer	0.00151	0.00616	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Fluorouracil—colon cancer	0.00147	0.006	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Fluorouracil—colon cancer	0.00147	0.00598	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Fluorouracil—colon cancer	0.00142	0.0058	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Irinotecan—colon cancer	0.00142	0.00578	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Fluorouracil—colon cancer	0.00141	0.00577	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Methotrexate—colon cancer	0.0014	0.00572	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Fluorouracil—colon cancer	0.00136	0.00554	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Fluorouracil—colon cancer	0.00134	0.00548	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Methotrexate—colon cancer	0.00132	0.0054	CcSEcCtD
Pentosan Polysulfate—Mood swings—Capecitabine—colon cancer	0.00129	0.00528	CcSEcCtD
Pentosan Polysulfate—Alopecia—Vincristine—colon cancer	0.00128	0.00523	CcSEcCtD
Pentosan Polysulfate—Dehydration—Capecitabine—colon cancer	0.00127	0.00519	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Methotrexate—colon cancer	0.00127	0.00517	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Methotrexate—colon cancer	0.00127	0.00517	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Capecitabine—colon cancer	0.00126	0.00515	CcSEcCtD
Pentosan Polysulfate—Alopecia—Irinotecan—colon cancer	0.00125	0.00509	CcSEcCtD
Pentosan Polysulfate—Flatulence—Irinotecan—colon cancer	0.00121	0.00495	CcSEcCtD
Pentosan Polysulfate—Gastritis—Capecitabine—colon cancer	0.00121	0.00494	CcSEcCtD
Pentosan Polysulfate—Alopecia—Fluorouracil—colon cancer	0.0012	0.00488	CcSEcCtD
Pentosan Polysulfate—Anaemia—Vincristine—colon cancer	0.00117	0.00476	CcSEcCtD
Pentosan Polysulfate—Agitation—Vincristine—colon cancer	0.00116	0.00474	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Methotrexate—colon cancer	0.00116	0.00473	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Capecitabine—colon cancer	0.00115	0.0047	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Capecitabine—colon cancer	0.00115	0.0047	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Irinotecan—colon cancer	0.00114	0.00466	CcSEcCtD
Pentosan Polysulfate—Anaemia—Irinotecan—colon cancer	0.00114	0.00464	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Capecitabine—colon cancer	0.00113	0.00462	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Vincristine—colon cancer	0.00113	0.00461	CcSEcCtD
Pentosan Polysulfate—Malaise—Irinotecan—colon cancer	0.00111	0.00453	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Irinotecan—colon cancer	0.0011	0.00449	CcSEcCtD
Pentosan Polysulfate—Anaemia—Fluorouracil—colon cancer	0.00109	0.00444	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Capecitabine—colon cancer	0.00108	0.0044	CcSEcCtD
Pentosan Polysulfate—Myalgia—Vincristine—colon cancer	0.00108	0.00439	CcSEcCtD
Pentosan Polysulfate—Weight increased—Capecitabine—colon cancer	0.00108	0.00439	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Capecitabine—colon cancer	0.00107	0.00436	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Fluorouracil—colon cancer	0.00105	0.0043	CcSEcCtD
Pentosan Polysulfate—Depression—Capecitabine—colon cancer	0.00105	0.00429	CcSEcCtD
Pentosan Polysulfate—Discomfort—Irinotecan—colon cancer	0.00103	0.00422	CcSEcCtD
Pentosan Polysulfate—Oedema—Vincristine—colon cancer	0.00103	0.00421	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Capecitabine—colon cancer	0.00103	0.00419	CcSEcCtD
Pentosan Polysulfate—Jaundice—Capecitabine—colon cancer	0.00103	0.00419	CcSEcCtD
Pentosan Polysulfate—Infection—Vincristine—colon cancer	0.00102	0.00418	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Capecitabine—colon cancer	0.00102	0.00418	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vincristine—colon cancer	0.00101	0.00412	CcSEcCtD
Pentosan Polysulfate—Haematuria—Capecitabine—colon cancer	0.001	0.0041	CcSEcCtD
Pentosan Polysulfate—Oedema—Irinotecan—colon cancer	0.001	0.0041	CcSEcCtD
Pentosan Polysulfate—Myalgia—Fluorouracil—colon cancer	0.001	0.00409	CcSEcCtD
Pentosan Polysulfate—Infection—Irinotecan—colon cancer	0.000997	0.00407	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Vincristine—colon cancer	0.000996	0.00407	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Capecitabine—colon cancer	0.000994	0.00405	CcSEcCtD
Pentosan Polysulfate—Discomfort—Fluorouracil—colon cancer	0.000991	0.00404	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Irinotecan—colon cancer	0.000983	0.00401	CcSEcCtD
Pentosan Polysulfate—Anorexia—Vincristine—colon cancer	0.000983	0.00401	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Irinotecan—colon cancer	0.00097	0.00396	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methotrexate—colon cancer	0.000964	0.00393	CcSEcCtD
Pentosan Polysulfate—Oedema—Fluorouracil—colon cancer	0.000961	0.00392	CcSEcCtD
Pentosan Polysulfate—Anorexia—Irinotecan—colon cancer	0.000957	0.0039	CcSEcCtD
Pentosan Polysulfate—Infection—Fluorouracil—colon cancer	0.000955	0.0039	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Capecitabine—colon cancer	0.000948	0.00387	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Fluorouracil—colon cancer	0.000941	0.00384	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—colon cancer	0.00094	0.00383	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000939	0.00383	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Capecitabine—colon cancer	0.000939	0.00383	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vincristine—colon cancer	0.000932	0.0038	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vincristine—colon cancer	0.000926	0.00378	CcSEcCtD
Pentosan Polysulfate—Anorexia—Fluorouracil—colon cancer	0.000916	0.00374	CcSEcCtD
Pentosan Polysulfate—Insomnia—Irinotecan—colon cancer	0.000908	0.0037	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Irinotecan—colon cancer	0.000901	0.00368	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vincristine—colon cancer	0.000896	0.00366	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Irinotecan—colon cancer	0.000895	0.00365	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Irinotecan—colon cancer	0.000884	0.00361	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Capecitabine—colon cancer	0.000882	0.0036	CcSEcCtD
Pentosan Polysulfate—Constipation—Vincristine—colon cancer	0.000881	0.0036	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000876	0.00357	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Irinotecan—colon cancer	0.000873	0.00356	CcSEcCtD
Pentosan Polysulfate—Insomnia—Fluorouracil—colon cancer	0.00087	0.00355	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Fluorouracil—colon cancer	0.000863	0.00352	CcSEcCtD
Pentosan Polysulfate—Constipation—Irinotecan—colon cancer	0.000858	0.0035	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Fluorouracil—colon cancer	0.000857	0.0035	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Fluorouracil—colon cancer	0.000846	0.00345	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—colon cancer	0.000843	0.00344	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vincristine—colon cancer	0.000843	0.00344	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Fluorouracil—colon cancer	0.000836	0.00341	CcSEcCtD
Pentosan Polysulfate—Alopecia—Capecitabine—colon cancer	0.000836	0.00341	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Irinotecan—colon cancer	0.000827	0.00338	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Irinotecan—colon cancer	0.000821	0.00335	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vincristine—colon cancer	0.000815	0.00332	CcSEcCtD
Pentosan Polysulfate—Flatulence—Capecitabine—colon cancer	0.000811	0.00331	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—colon cancer	0.000803	0.00328	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Irinotecan—colon cancer	0.000794	0.00324	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Fluorouracil—colon cancer	0.000792	0.00323	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—colon cancer	0.000782	0.00319	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—colon cancer	0.000764	0.00312	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Capecitabine—colon cancer	0.000764	0.00312	CcSEcCtD
Pentosan Polysulfate—Urticaria—Fluorouracil—colon cancer	0.000764	0.00312	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—colon cancer	0.000762	0.00311	CcSEcCtD
Pentosan Polysulfate—Anaemia—Capecitabine—colon cancer	0.000761	0.0031	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vincristine—colon cancer	0.000759	0.0031	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—colon cancer	0.000752	0.00307	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—colon cancer	0.000748	0.00305	CcSEcCtD
Pentosan Polysulfate—Malaise—Capecitabine—colon cancer	0.000742	0.00303	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—colon cancer	0.00074	0.00302	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Irinotecan—colon cancer	0.00074	0.00302	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Capecitabine—colon cancer	0.000737	0.00301	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Fluorouracil—colon cancer	0.000708	0.00289	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vincristine—colon cancer	0.000705	0.00288	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Capecitabine—colon cancer	0.000701	0.00286	CcSEcCtD
Pentosan Polysulfate—Myalgia—Capecitabine—colon cancer	0.000701	0.00286	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—colon cancer	0.000699	0.00285	CcSEcCtD
Pentosan Polysulfate—Discomfort—Capecitabine—colon cancer	0.000692	0.00283	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Irinotecan—colon cancer	0.000687	0.0028	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vincristine—colon cancer	0.000682	0.00278	CcSEcCtD
Pentosan Polysulfate—Pruritus—Fluorouracil—colon cancer	0.00068	0.00278	CcSEcCtD
Pentosan Polysulfate—Oedema—Capecitabine—colon cancer	0.000672	0.00274	CcSEcCtD
Pentosan Polysulfate—Infection—Capecitabine—colon cancer	0.000667	0.00272	CcSEcCtD
Pentosan Polysulfate—Dizziness—Irinotecan—colon cancer	0.000664	0.00271	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Fluorouracil—colon cancer	0.000658	0.00268	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Capecitabine—colon cancer	0.000658	0.00268	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—colon cancer	0.000656	0.00268	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—colon cancer	0.000655	0.00267	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—colon cancer	0.00065	0.00265	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Capecitabine—colon cancer	0.00065	0.00265	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—colon cancer	0.000649	0.00265	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—colon cancer	0.000646	0.00263	CcSEcCtD
Pentosan Polysulfate—Anorexia—Capecitabine—colon cancer	0.00064	0.00261	CcSEcCtD
Pentosan Polysulfate—Vomiting—Irinotecan—colon cancer	0.000638	0.0026	CcSEcCtD
Pentosan Polysulfate—Dizziness—Fluorouracil—colon cancer	0.000636	0.00259	CcSEcCtD
Pentosan Polysulfate—Rash—Irinotecan—colon cancer	0.000633	0.00258	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Irinotecan—colon cancer	0.000632	0.00258	CcSEcCtD
Pentosan Polysulfate—Headache—Irinotecan—colon cancer	0.000629	0.00257	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—colon cancer	0.000622	0.00254	CcSEcCtD
Pentosan Polysulfate—Nausea—Vincristine—colon cancer	0.000612	0.0025	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000612	0.0025	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fluorouracil—colon cancer	0.000611	0.00249	CcSEcCtD
Pentosan Polysulfate—Insomnia—Capecitabine—colon cancer	0.000608	0.00248	CcSEcCtD
Pentosan Polysulfate—Rash—Fluorouracil—colon cancer	0.000606	0.00247	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fluorouracil—colon cancer	0.000606	0.00247	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Capecitabine—colon cancer	0.000603	0.00246	CcSEcCtD
Pentosan Polysulfate—Headache—Fluorouracil—colon cancer	0.000602	0.00246	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Capecitabine—colon cancer	0.000599	0.00244	CcSEcCtD
Pentosan Polysulfate—Nausea—Irinotecan—colon cancer	0.000596	0.00243	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Capecitabine—colon cancer	0.000591	0.00241	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Capecitabine—colon cancer	0.000584	0.00238	CcSEcCtD
Pentosan Polysulfate—Constipation—Capecitabine—colon cancer	0.000575	0.00234	CcSEcCtD
Pentosan Polysulfate—Nausea—Fluorouracil—colon cancer	0.000571	0.00233	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—colon cancer	0.000569	0.00232	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—colon cancer	0.000566	0.00231	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Capecitabine—colon cancer	0.000554	0.00226	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—colon cancer	0.000553	0.00225	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Capecitabine—colon cancer	0.000549	0.00224	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—colon cancer	0.000549	0.00224	CcSEcCtD
Pentosan Polysulfate—Urticaria—Capecitabine—colon cancer	0.000534	0.00218	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Capecitabine—colon cancer	0.000531	0.00217	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—colon cancer	0.000522	0.00213	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—colon cancer	0.000522	0.00213	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—colon cancer	0.000515	0.0021	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—colon cancer	0.000497	0.00203	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Capecitabine—colon cancer	0.000495	0.00202	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—colon cancer	0.00049	0.002	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—colon cancer	0.000484	0.00197	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—colon cancer	0.000477	0.00195	CcSEcCtD
Pentosan Polysulfate—Pruritus—Capecitabine—colon cancer	0.000475	0.00194	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Capecitabine—colon cancer	0.00046	0.00188	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000456	0.00186	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—colon cancer	0.000452	0.00185	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—colon cancer	0.000449	0.00183	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—colon cancer	0.000446	0.00182	CcSEcCtD
Pentosan Polysulfate—Dizziness—Capecitabine—colon cancer	0.000444	0.00181	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—colon cancer	0.00044	0.0018	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—colon cancer	0.000435	0.00177	CcSEcCtD
Pentosan Polysulfate—Vomiting—Capecitabine—colon cancer	0.000427	0.00174	CcSEcCtD
Pentosan Polysulfate—Rash—Capecitabine—colon cancer	0.000424	0.00173	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Capecitabine—colon cancer	0.000423	0.00173	CcSEcCtD
Pentosan Polysulfate—Headache—Capecitabine—colon cancer	0.000421	0.00172	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—colon cancer	0.000412	0.00168	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—colon cancer	0.000409	0.00167	CcSEcCtD
Pentosan Polysulfate—Nausea—Capecitabine—colon cancer	0.000399	0.00163	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—colon cancer	0.000397	0.00162	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—colon cancer	0.000395	0.00161	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—colon cancer	0.000368	0.0015	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—colon cancer	0.000354	0.00144	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—colon cancer	0.000342	0.0014	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—colon cancer	0.000331	0.00135	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—colon cancer	0.000318	0.0013	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—colon cancer	0.000315	0.00129	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—colon cancer	0.000315	0.00129	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—colon cancer	0.000313	0.00128	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—colon cancer	0.000297	0.00121	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—EP300—colon cancer	0.000213	0.000375	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—FGFR3—colon cancer	0.000213	0.000375	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—colon cancer	0.000213	0.000374	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	0.000211	0.000372	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—AKT1—colon cancer	0.000211	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—AKT1—colon cancer	0.000211	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	0.000211	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—SRC—colon cancer	0.000211	0.00037	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—AKT1—colon cancer	0.000209	0.000367	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	0.000208	0.000366	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—SRC—colon cancer	0.000208	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—AKT1—colon cancer	0.000207	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000207	0.000364	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—AKT1—colon cancer	0.000206	0.000363	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—AKT1—colon cancer	0.000206	0.000362	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—AKT1—colon cancer	0.000205	0.000361	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—FGFR3—colon cancer	0.000205	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—AKT1—colon cancer	0.000204	0.000359	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—NRAS—colon cancer	0.000203	0.000356	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—colon cancer	0.000202	0.000356	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—colon cancer	0.000201	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	0.000201	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—TGFB1—colon cancer	0.000201	0.000353	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NRAS—colon cancer	0.0002	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—SRC—colon cancer	0.000199	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000198	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—FGFR3—colon cancer	0.000198	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—AKT1—colon cancer	0.000195	0.000343	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	0.000193	0.000339	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—AKT1—colon cancer	0.000192	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—AKT1—colon cancer	0.000192	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	0.000192	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NRAS—colon cancer	0.000192	0.000337	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KRAS—colon cancer	0.000191	0.000336	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—AKT1—colon cancer	0.00019	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDH1—colon cancer	0.00019	0.000333	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000189	0.000332	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—AKT1—colon cancer	0.000188	0.000331	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	0.000187	0.000328	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—colon cancer	0.000185	0.000325	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—colon cancer	0.000182	0.00032	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—APC—colon cancer	0.000182	0.00032	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDH1—colon cancer	0.000181	0.000319	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000181	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—AKT1—colon cancer	0.000178	0.000313	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—PIK3CA—colon cancer	0.000176	0.000309	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—colon cancer	0.000175	0.000307	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KRAS—colon cancer	0.000174	0.000307	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDH1—colon cancer	0.000173	0.000304	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KRAS—colon cancer	0.000172	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—BRAF—colon cancer	0.000171	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	0.00017	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD8A—colon cancer	0.000166	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—colon cancer	0.000165	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—colon cancer	0.000163	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—PIK3CA—colon cancer	0.00016	0.000282	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—PIK3CA—colon cancer	0.000158	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD8A—colon cancer	0.000152	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PIK3CA—colon cancer	0.000152	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CTNNB1—colon cancer	0.00015	0.000265	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—colon cancer	0.000148	0.000261	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—colon cancer	0.000146	0.000257	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CTNNB1—colon cancer	0.000146	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—colon cancer	0.000144	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CDKN1A—colon cancer	0.000142	0.00025	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2L1—colon cancer	0.000142	0.00025	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—colon cancer	0.00014	0.000247	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EP300—colon cancer	0.00014	0.000246	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGFR3—colon cancer	0.000139	0.000244	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—colon cancer	0.000138	0.000243	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDKN1A—colon cancer	0.000137	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGFR3—colon cancer	0.000136	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—SRC—colon cancer	0.000136	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EP300—colon cancer	0.000135	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CTNNB1—colon cancer	0.000134	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CTNNB1—colon cancer	0.000133	0.000234	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—colon cancer	0.000132	0.000233	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—SRC—colon cancer	0.000132	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—colon cancer	0.000131	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—colon cancer	0.000131	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1A—colon cancer	0.000131	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1A—colon cancer	0.00013	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2L1—colon cancer	0.00013	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—colon cancer	0.000129	0.000227	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APC—colon cancer	0.000127	0.000224	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—colon cancer	0.000127	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—SRC—colon cancer	0.000126	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGFR3—colon cancer	0.000126	0.000221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1A—colon cancer	0.000125	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EP300—colon cancer	0.000124	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FGFR3—colon cancer	0.000124	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—colon cancer	0.000124	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EP300—colon cancer	0.000124	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CTNNB1—colon cancer	0.000123	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—colon cancer	0.000122	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—colon cancer	0.000122	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—SRC—colon cancer	0.000121	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1A—colon cancer	0.000121	0.000212	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—SRC—colon cancer	0.00012	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—colon cancer	0.00012	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—colon cancer	0.000119	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—colon cancer	0.000116	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—colon cancer	0.000116	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—colon cancer	0.000115	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APC—colon cancer	0.000115	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—SRC—colon cancer	0.000115	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDH1—colon cancer	0.000115	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EP300—colon cancer	0.000115	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FGFR3—colon cancer	0.000115	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—colon cancer	0.000113	0.000198	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SRC—colon cancer	0.000112	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—colon cancer	0.000111	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—colon cancer	0.000111	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—colon cancer	0.000109	0.000192	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—colon cancer	0.000108	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—colon cancer	0.000107	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—colon cancer	0.000106	0.000186	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—colon cancer	0.000105	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—colon cancer	0.000105	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—colon cancer	0.000105	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—colon cancer	0.000105	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—colon cancer	0.000101	0.000178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—colon cancer	0.0001	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—colon cancer	0.0001	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—colon cancer	0.0001	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—colon cancer	9.98e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—colon cancer	9.95e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—colon cancer	9.89e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—colon cancer	9.78e-05	0.000172	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—colon cancer	9.62e-05	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—colon cancer	9.57e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—colon cancer	9.55e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—colon cancer	9.27e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—colon cancer	9.24e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—colon cancer	9.19e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—colon cancer	9.14e-05	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—colon cancer	8.97e-05	0.000158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—colon cancer	8.9e-05	0.000157	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR3—colon cancer	8.8e-05	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—colon cancer	8.77e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—colon cancer	8.76e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—colon cancer	8.73e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—colon cancer	8.65e-05	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—colon cancer	8.51e-05	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—colon cancer	8.49e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—colon cancer	8.49e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—colon cancer	8.45e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—colon cancer	8.45e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—colon cancer	8.45e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—colon cancer	8.29e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—colon cancer	8.19e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—colon cancer	8.12e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—colon cancer	8.08e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—colon cancer	8.04e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR3—colon cancer	8.02e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—colon cancer	7.99e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—colon cancer	7.89e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—colon cancer	7.86e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—colon cancer	7.85e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—colon cancer	7.84e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—colon cancer	7.81e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—colon cancer	7.74e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—colon cancer	7.67e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—colon cancer	7.66e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—colon cancer	7.61e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—colon cancer	7.59e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—colon cancer	7.56e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—colon cancer	7.52e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—colon cancer	7.51e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—colon cancer	7.46e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—colon cancer	7.38e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—colon cancer	7.37e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—colon cancer	7.28e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—colon cancer	7.19e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—colon cancer	7.17e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—colon cancer	7.15e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—colon cancer	7.08e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—colon cancer	7e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—colon cancer	7e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—colon cancer	6.99e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—colon cancer	6.98e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—colon cancer	6.94e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—colon cancer	6.92e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—colon cancer	6.85e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—colon cancer	6.81e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—colon cancer	6.73e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—colon cancer	6.72e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—colon cancer	6.64e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—colon cancer	6.47e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—colon cancer	6.46e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—colon cancer	6.35e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—colon cancer	6.35e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—colon cancer	6.33e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—colon cancer	6.21e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—colon cancer	6.21e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—colon cancer	6.13e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—colon cancer	5.94e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—colon cancer	5.87e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—colon cancer	5.84e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—colon cancer	5.79e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—colon cancer	5.79e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—colon cancer	5.77e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—colon cancer	5.75e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—colon cancer	5.69e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—colon cancer	5.66e-05	9.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—colon cancer	5.54e-05	9.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—colon cancer	5.5e-05	9.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—colon cancer	5.49e-05	9.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—colon cancer	5.4e-05	9.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—colon cancer	5.39e-05	9.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—colon cancer	5.36e-05	9.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—colon cancer	5.35e-05	9.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—colon cancer	5.32e-05	9.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—colon cancer	5.19e-05	9.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—colon cancer	5.1e-05	8.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—colon cancer	5.05e-05	8.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—colon cancer	5e-05	8.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—colon cancer	4.99e-05	8.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—colon cancer	4.96e-05	8.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—colon cancer	4.92e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—colon cancer	4.91e-05	8.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—colon cancer	4.89e-05	8.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—colon cancer	4.86e-05	8.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—colon cancer	4.83e-05	8.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—colon cancer	4.77e-05	8.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—colon cancer	4.77e-05	8.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—colon cancer	4.65e-05	8.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—colon cancer	4.55e-05	8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—colon cancer	4.52e-05	7.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—colon cancer	4.45e-05	7.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—colon cancer	4.43e-05	7.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—colon cancer	4.41e-05	7.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—colon cancer	4.4e-05	7.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—colon cancer	4.35e-05	7.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—colon cancer	4.35e-05	7.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—colon cancer	4.35e-05	7.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—colon cancer	4.11e-05	7.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—colon cancer	4.05e-05	7.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—colon cancer	4.04e-05	7.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—colon cancer	4.01e-05	7.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—colon cancer	3.96e-05	6.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—colon cancer	3.77e-05	6.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—colon cancer	3.75e-05	6.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—colon cancer	3.65e-05	6.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—colon cancer	3.49e-05	6.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—colon cancer	3.44e-05	6.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—colon cancer	3.33e-05	5.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—colon cancer	3.18e-05	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—colon cancer	3.08e-05	5.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—colon cancer	2.81e-05	4.94e-05	CbGpPWpGaD
